oxycodone has been researched along with tapentadol in 91 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (4.40) | 29.6817 |
| 2010's | 60 (65.93) | 24.3611 |
| 2020's | 27 (29.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brockmöller, J; Friesacher, HR; Meyer, MJ; Neumann, VE; Tzvetkov, MV; Zdrazil, B | 1 |
| Daniels, SE; Häeussler, J; Lange, C; Okamoto, A; Upmalis, D | 1 |
| Hale, M; Lange, C; Okamoto, A; Rauschkolb, C; Upmalis, D | 1 |
| Hartrick, C; Oh, C; Stegmann, JU; Upmalis, D; Van Hove, I | 1 |
| Casson, E; Daniels, S; Oh, C; Okamoto, A; Rauschkolb, C; Stegmann, JU; Upmalis, D | 1 |
| Ashworth, J; Etropolski, M; Häufel, T; Kuperwasser, B; Lange, B; Okamoto, A; Steup, A | 1 |
| Afilalo, M; Etropolski, MS; Haeussler, J; Kelly, K; Kuperwasser, B; Lange, B; Okamoto, A; Rauschkolb, C; Steup, A; Van Hove, I | 1 |
| Frampton, JE | 1 |
| Haber, NA; Kavanagh, S; Kwong, WJ; Miller, JD; Ozer-Stillman, I; Russell, MW | 1 |
| Etropolski, M; Kelly, K; Okamoto, A; Rauschkolb, C | 1 |
| Christoph, T; De Vry, J; Schiene, K; Tallarida, RJ; Tzschentke, TM | 1 |
| Cepeda, MS; Kim, M; Sutton, A; Weinstein, R | 1 |
| Boldingh, A; Burton, D; Busciglio, I; Camilleri, M; Iturrino, J; Jeong, ID; Rhoten, D; Ryks, M; Shin, A; Zinsmeister, AR | 1 |
| Baxter, G; Conway, P; Hertel, N; Ikenberg, R; Liedgens, H; Moore, RA; Obradovic, M | 1 |
| Dinges, G; Koch, T; Kranke, P; Merker, M; Morin, AM | 1 |
| Etropolski, M; Lin, R; Nandy, P; Okamoto, A; Upmalis, D; Xu, XS | 1 |
| Hammond, GC; Kavanagh, S; Kwong, WJ; Nelson, W; Upmalis, D; Yang, M | 1 |
| Benson, C; Biondi, D; Chang, H; Chow, W; Kim, MS; Lerner, D; Rogers, WH | 1 |
| Kim, M; Vorsanger, G | 1 |
| Merchant, S; Mody, SH; Neil, N; Ogden, K; Provenzano, D | 1 |
| Cepeda, MS; Fife, D; Mastrogiovanni, G; Vo, L; Yuan, Y | 1 |
| Ashworth, JB; Comer, SD; Jones, JD; Manubay, JM; Shapiro, DY; Vosburg, SK | 1 |
| Chow, W; Kim, MS; Lin, J; Rupnow, MF | 1 |
| Falke, D; Gálvez, R; Hans, G; Schäfer, M; Steigerwald, I | 1 |
| Duff, S; Gricar, J; Howe, A; Merchant, S; Mody, SH; Noe, LL; Ogden, K | 1 |
| Hammond, G; Kavanagh, S; Kwong, WJ; Okamoto, A; Upmalis, D; Yang, M | 1 |
| Cepeda, MS; Fife, D; Ma, Q; Ryan, PB | 1 |
| Cepeda, MS; Fife, D; Kihm, MA; Mastrogiovanni, G; Yuan, Y | 1 |
| Raeder, J | 1 |
| Coluzzi, F; Ruggeri, M | 2 |
| Kanbara, T; Kanemasa, T; Minami, K; Nakamura, A; Ono, H; Sakaguchi, G; Shinohara, S | 1 |
| Etropolski, M; Flügel, M; Häufel, T; Kuperwasser, B; Lange, B; Laschewski, F; Rauschkolb, C | 1 |
| Kern, KU; Krings, D; Waldmann-Rex, S | 1 |
| Bernardy, K; Häuser, W; Maier, C | 1 |
| Dickerson, S; Junor, R; Kumar Bhutani, M; Thakur, D | 1 |
| Benson, C; Biondi, DM; Dworkin, RH; Katz, NP; Kim, M; Trudeau, JJ; Turk, DC | 1 |
| Duse, G; Ferrari, R; Visentin, M; Zanolin, ME | 1 |
| Hock, K; Mullins, ME; Scott, MG | 1 |
| Alarcão, J; Costa, J; Fareleira, F; Santos, J; Vaz-Carneiro, A | 1 |
| Ando, Y; Gyawali, B; Hayashi, N; Honda, K; Shimokata, T; Tsukuura, H | 1 |
| Baron, R; Blanco, FJ; Falke, D; Kennes, L; Likar, R; Martin-Mola, E; Müller, M; Steigerwald, I | 1 |
| Arsenault, P; Buynak, R; Etropolski, M; Heisig, F; Rappaport, SA; Rauschkolb, C; Rod, K | 1 |
| Baron, R; Binder, A; Falke, D; Jansen, JP; Kennes, L; Müller, M; Pombo-Suarez, M; Steigerwald, I | 1 |
| Iseki, M; Takahashi, Y | 1 |
| Kraus, S | 1 |
| Kathmann, W | 1 |
| Aldridge, L; Cantrell, FL; Mallett, P; McIntyre, IM; Verilhac, K | 1 |
| Lange, B; Serrie, A; Steup, A | 1 |
| Dubois, C; Elling, C; Lange, B; von Zabern, D | 1 |
| Bell, RF; Derry, S; Moore, RA; Wee, B; Wiffen, PJ | 1 |
| Ahrens, J; Haeseler, G; Karch, A; Liu, X; Prison, N; Schaefers, D | 1 |
| Dahan, A; Drewes, AM; Jonkman, K; Niesters, M; Olofsen, E; van der Schrier, R; van Velzen, M | 1 |
| Cicero, TJ; Dart, RC; Green, JL; Kurtz, SP; Parrino, MW; Severtson, SG; Vosburg, SK | 1 |
| Goto, A; Honda, Y; Ichikawa, Y; Kessoku, T; Kusakabe, A; Matsuura, T; Nakajima, A; Sukegawa, A; Yoshida, H; Yoshimi, A | 1 |
| Elling, C; Lange, B; Sohns, M; Tempero, J | 1 |
| Ammar, D; Baron, L; Chvetzoff, G; Collin, E; Delorme, C; Delorme, T; Faure, S; Filbet, M; Hubault, P; Jovenin, N; Krakowski, I; Magnet, M; Michenot, N; Minello, C; Poulain, P; Rostaing, S | 1 |
| Ahmed, N; Close, J; Duff, S; Ffrench-O'Carroll, R; Immanni, S; McNamara, J; Murray, M; Rice, T; Steinhaeuser, H | 1 |
| Bradford, WD; Nguyen, TD; Simon, KI | 1 |
| Baxter, G; Currie, C; Jenkins-Jones, S; Morgan, CL | 1 |
| Futamura, A; Nakagawa, T; Suga, Y; Sugawara, H; Suzuki, S; Takase, H; Torigoe, K; Uchida, M; Uesawa, Y | 1 |
| Brás, M; Fragoso, M; Vieira, C | 1 |
| Häuser, W; Klose, P; Petzke, F; Sommer, C; Welsch, P | 1 |
| Narayan, SW; Patanwala, AE; Penm, J; Wang, X | 1 |
| Crossin, R; Lam, T; Lubman, DI; Matthews, S; Nielsen, S; Scott, D; Smith, K; Wilson, J | 1 |
| Egeberg, T; Hofstad, J; Husby, VS; Høvik, L; Klaksvik, J; Klepstad, P; Rian, T; Sand, K; Skogvoll, E; Wik, TS; Winther, SB | 1 |
| Finco, G; Karra, R; Liedgens, H; Margarit, C; Morlion, BJ; Sohns, M; Wild, I | 1 |
| Comelon, M; Drægni, T; Lenz, H; Lieng, M; Raeder, J | 1 |
| Drewes, AM; Frøkjær, JB; Hansen, TM; Mark, EB; Nedergaard, RB | 1 |
| Johnstone, C; Narayan, SW; Patanwala, AE; Penm, J; Wang, X | 1 |
| Drewes, AM; Frøkjaer, JB; Hansen, TM; Krogh, K; Mark, EB; Nedergaard, RB; Nissen, TD; Scott, SM | 1 |
| Narayan, SW; Patanwala, AE; Penm, J; Tay, HP; Wang, X | 1 |
| Croosu, SS; Drewes, AM; Frøkjaer, JB; Hansen, TM | 1 |
| Drewes, AM; Frøkjaer, JB; Hansen, TM; Mark, EB | 1 |
| Brock, C; Drewes, AM; Hansen, TM; Mark, EB; Nedergaard, RB; Nissen, TD | 1 |
| Matsuda, Y; Niki, K; Okamoto, Y; Omae, T; Takagi, T; Takemura, M; Ueda, M | 1 |
| Caravaggio, S; Coluzzi, F; Rosiello, F; Ruggeri, M; Santori, C; Signorini, A | 1 |
| Patanwala, AE; Penm, J; Wang, X | 1 |
| Bau, G; Black, J; Dart, RC; Iwanicki, JL; Margolin, ZR; Olson, R | 1 |
| Saitoh, A; Sato, T; Shino, M; Sugiyama, Y; Tanaka, R; Yamada, D | 1 |
| Connor, M; Manandhar, P; Santiago, M | 1 |
| Biggs, N; da Gama, M; Evans, J; Lam, T; Lubman, DI; Nielsen, S; Stevens, J; Xia, T | 1 |
| Atayee, RS; Edmonds, KP; Wen, RY | 1 |
| Barrachina, J; Inda, MD; López-Gil, S; López-Gil, V; Margarit, C; Morales, D; Muriel, J; Peiró, AM; Planelles, B; Vara-González, A | 1 |
| Buckley, NA; Chan, BS; Chiew, AL; Mirabella, J; Ravi, D | 1 |
| Dahan, A; Drewes, AM; Hansen, TM; Mørch, CD; Nedergaard, RB; Niesters, M | 1 |
| Biggs, N; Cheng, O; da Gama, ME; Evans, JD; Kabu, K; Lam, T; Lubman, DI; Nielsen, S; Stevens, JA; Treloar, M; Xia, T | 1 |
| Boland, JW | 1 |
| Husby, VS; Klaksvik, J; Rian, T; Wik, TS; Winther, SB | 1 |
19 review(s) available for oxycodone and tapentadol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain.
Topics: Aged; Analgesics, Opioid; Analysis of Variance; Chronic Disease; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Least-Squares Analysis; Low Back Pain; Male; Middle Aged; Osteoarthritis, Knee; Oxycodone; Pain Measurement; Phenols; Quality of Life; Randomized Controlled Trials as Topic; Safety; Severity of Illness Index; Tapentadol; Treatment Outcome | 2010 |
Tapentadol immediate release: a review of its use in the treatment of moderate to severe acute pain.
Topics: Analgesics; Analgesics, Opioid; Animals; Clinical Trials as Topic; Drug Interactions; Humans; Oxycodone; Pain; Phenols; Receptors, Opioid, mu; Severity of Illness Index; Tapentadol | 2010 |
[Undesired side effects of tapentadol in comparison to oxycodone. A meta-analysis of randomized controlled comparative studies].
Topics: Adverse Drug Reaction Reporting Systems; Analgesics, Opioid; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Oxycodone; Pain; Phenols; Randomized Controlled Trials as Topic; Risk; Tapentadol | 2012 |
Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain.
Topics: Chronic Pain; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Italy; Musculoskeletal Pain; Naloxone; Oxycodone; Phenols; Tapentadol; Treatment Outcome | 2014 |
Safety and tolerability of tapentadol extended release in moderate to severe chronic osteoarthritis or low back pain management: pooled analysis of randomized controlled trials.
Topics: Adult; Aged; Analgesics; Chronic Pain; Delayed-Action Preparations; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Oxycodone; Pain Management; Pain Measurement; Phenols; Randomized Controlled Trials as Topic; Receptors, Opioid, mu; Tapentadol; Treatment Outcome | 2014 |
[Clinical and economical evaluation of new analgesics for the management of chronic pain].
Topics: Analgesics, Opioid; Chronic Pain; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Economics, Pharmaceutical; Humans; Models, Economic; Naloxone; Oxycodone; Phenols; Quality of Life; Quality-Adjusted Life Years; Tapentadol | 2014 |
[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks].
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Hydromorphone; Long-Term Care; Morphine; Oxycodone; Oxymorphone; Pain Measurement; Phenols; Randomized Controlled Trials as Topic; Tapentadol; Tramadol; Treatment Outcome | 2015 |
Impact of prolonged-release oxycodone/naloxone on outcomes affecting patients' daily functioning in comparison with extended-release tapentadol: a systematic review.
Topics: Chronic Pain; Constipation; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Headache; Humans; Naloxone; Nausea; Oxycodone; Phenols; Quality of Life; Tapentadol; Vomiting | 2015 |
Tapentadol for chronic musculoskeletal pain in adults.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Clinical Trials, Phase III as Topic; Humans; Low Back Pain; Musculoskeletal Pain; Osteoarthritis, Knee; Oxycodone; Phenols; Randomized Controlled Trials as Topic; Tapentadol | 2015 |
Opioid-induced constipation.
Topics: Chloride Channel Agonists; Chronic Pain; Constipation; Humans; Laxatives; Lubiprostone; Naloxone; Oxycodone; Peptides; Phenols; Receptors, Opioid, mu; Tapentadol | 2015 |
Efficacy and safety of tapentadol prolonged release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled release-controlled studies.
Topics: Aged; Chronic Pain; Constipation; Delayed-Action Preparations; Double-Blind Method; Female; Health Status; Humans; Male; Middle Aged; Nausea; Osteoarthritis, Knee; Oxycodone; Phenols; Randomized Controlled Trials as Topic; Tapentadol; Vomiting | 2017 |
Opioids for cancer pain - an overview of Cochrane reviews.
Topics: Acetaminophen; Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Fentanyl; Humans; Hydromorphone; Methadone; Oxycodone; Phenols; Review Literature as Topic; Tapentadol; Tramadol | 2017 |
Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo-, and active-controlled trials.
Topics: Aged; Chronic Pain; Clinical Trials, Phase III as Topic; Constipation; Delayed-Action Preparations; Double-Blind Method; Female; Health Status Indicators; Humans; Male; Middle Aged; Nausea; Osteoarthritis, Knee; Oxycodone; Randomized Controlled Trials as Topic; Tapentadol; Vertigo; Vomiting | 2018 |
[Opioid switch and change of route of administration in cancer patients treated by morphine].
Topics: Administration, Oral; Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Drug Substitution; Fentanyl; France; Humans; Hydromorphone; Injections, Intravenous; Injections, Subcutaneous; Methadone; Morphine; Oxycodone; Phenols; Tapentadol | 2018 |
[Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review].
Topics: Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Deglutition Disorders; Fentanyl; Humans; Hydromorphone; Liver Failure; Morphine; Oxycodone; Renal Dialysis; Renal Insufficiency; Tapentadol; Tramadol | 2019 |
Opioids for chronic non-cancer neuropathic pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration.
Topics: Analgesics, Opioid; Chronic Pain; Humans; Morphine; Neuralgia; Oxycodone; Tapentadol | 2020 |
Efficacy and Safety of Tapentadol Immediate Release for Acute Pain: A Systematic Review and Meta-Analysis.
Topics: Acute Pain; Analgesics, Opioid; Humans; Observational Studies as Topic; Oxycodone; Randomized Controlled Trials as Topic; Tapentadol | 2020 |
Tapentadol for the management of cancer pain in adults: an update.
Topics: Adult; Analgesics; Analgesics, Opioid; Cancer Pain; Humans; Morphine; Multicenter Studies as Topic; Neoplasms; Oxycodone; Pain; Phenols; Quality of Life; Randomized Controlled Trials as Topic; Receptors, Opioid; Tapentadol | 2023 |
32 trial(s) available for oxycodone and tapentadol
| Article | Year |
|---|---|
A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain.
Topics: Adult; Double-Blind Method; Humans; Middle Aged; Oxycodone; Pain, Postoperative; Phenols; Placebos; Tapentadol | 2009 |
Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Double-Blind Method; Drug Administration Schedule; Drug Compounding; Female; Humans; Low Back Pain; Male; Middle Aged; Models, Biological; Osteoarthritis, Hip; Osteoarthritis, Knee; Oxycodone; Pain; Phenols; Tapentadol; Time Factors; Treatment Outcome | 2009 |
Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled
Topics: Adult; Aged; Analgesics, Opioid; Constipation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Osteoarthritis, Hip; Osteoarthritis, Knee; Oxycodone; Pain; Phenols; Tapentadol; Vomiting; Young Adult | 2009 |
A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain.
Topics: Acute Disease; Adult; Aged; Algorithms; Analgesics, Opioid; Dosage Forms; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxycodone; Pain; Phenols; Placebos; Tapentadol; Treatment Outcome | 2009 |
Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III
Topics: Aged; Analgesics; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Osteoarthritis, Knee; Oxycodone; Pain; Phenols; Tapentadol | 2010 |
Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride.
Topics: Aged; Analgesics, Opioid; Chronic Disease; Constipation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Joint Diseases; Male; Middle Aged; Nausea; Oxycodone; Pain; Phenols; Tapentadol; Vomiting | 2011 |
A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans.
Topics: Adult; Analgesics, Opioid; Double-Blind Method; Female; Gastrointestinal Transit; Humans; Male; Nausea; Oxycodone; Phenols; Receptors, Opioid, mu; Tapentadol | 2012 |
Pain relief and tolerability balance of immediate release tapentadol or oxycodone treatment for patients with moderate to severe osteoarthritis or low back pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis; Oxycodone; Phenols; Tapentadol; Young Adult | 2012 |
Imputing at-work productivity loss using results of a randomized controlled trial comparing tapentadol extended release and oxycodone controlled release for osteoarthritis pain.
Topics: Adult; Aged; Analgesics; Chronic Pain; Delayed-Action Preparations; Efficiency; Female; Humans; Male; Middle Aged; Osteoarthritis, Knee; Oxycodone; Phenols; Severity of Illness Index; Tapentadol | 2012 |
A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers.
Topics: Adult; Analgesics, Opioid; Chemistry, Pharmaceutical; Drug Packaging; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Particle Size; Patient Satisfaction; Phenols; Prescription Drug Misuse; Prescription Fees; Tablets; Tapentadol; Treatment Outcome; Young Adult | 2013 |
Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Constipation; Delayed-Action Preparations; Female; Fentanyl; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Morphine; Neuralgia; Oxycodone; Pain Measurement; Phenols; Severity of Illness Index; Tapentadol | 2013 |
Bowel function after tapentadol and oxycodone immediate release (IR) treatment in patients with low back or osteoarthritis pain.
Topics: Adolescent; Adult; Analgesics, Opioid; Constipation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Gastroenteritis; Humans; Laxatives; Low Back Pain; Male; Osteoarthritis; Oxycodone; Pain; Phenols; Surveys and Questionnaires; Tapentadol; Time Factors; Young Adult | 2013 |
[Tapentadol prolonged release improves analgesia, functional impairment and quality of life in patients with chronic pain who have previously received oxycodone/naloxone].
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Back Pain; Chronic Pain; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Substitution; Female; Germany; Humans; Male; Middle Aged; Naloxone; Oxycodone; Pain Measurement; Patient Satisfaction; Phenols; Prospective Studies; Quality of Life; Tapentadol | 2014 |
[Neuropathic back pain origins verified or cannot be excluded. Comparative pain study: retard tapentadol versus an established fixed combination].
Topics: Back Pain; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Humans; Naloxone; Neuralgia; Oxycodone; Pain Measurement; Patient Satisfaction; Phenols; Prospective Studies; Tapentadol | 2014 |
Validation of the Short-form McGill Pain Questionnaire-2 (SF-MPQ-2) in acute low back pain.
Topics: Acute Pain; Analgesics, Opioid; Double-Blind Method; Factor Analysis, Statistical; Female; Humans; Leg; Low Back Pain; Male; Middle Aged; Neuralgia; Oxycodone; Pain Measurement; Phenols; Psychometrics; Reproducibility of Results; Surveys and Questionnaires; Tapentadol | 2015 |
Effectiveness of Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-Label, Phase 3b/4 Study.
Topics: Adult; Aged; Analgesics, Opioid; Delayed-Action Preparations; Endpoint Determination; Female; Humans; Low Back Pain; Male; Middle Aged; Naloxone; Narcotic Antagonists; Neuralgia; Oxycodone; Pain Measurement; Phenols; Tapentadol | 2016 |
Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial.
Topics: Aged; Chronic Disease; Chronic Pain; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis, Knee; Oxycodone; Phenols; Quality of Life; Tapentadol | 2015 |
Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-label, Phase 3b/4 Trial.
Topics: Adult; Aged; Analgesics, Opioid; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Endpoint Determination; Female; Health Status; Humans; Low Back Pain; Male; Middle Aged; Naloxone; Narcotic Antagonists; Neuralgia; Oxycodone; Pain Measurement; Phenols; Quality of Life; Tapentadol | 2016 |
[Oxycodone/naloxone retard superior to tapentadol in the study].
Topics: Back Pain; Double-Blind Method; Drug Combinations; Naloxone; Neuralgia; Oxycodone; Pain Measurement; Phenols; Prospective Studies; Tapentadol | 2016 |
Tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a double-blind, randomized, placebo- and oxycodone controlled release-controlled study.
Topics: Aged; Chronic Pain; Constipation; Delayed-Action Preparations; Double-Blind Method; Female; Health Status; Humans; Male; Middle Aged; Nausea; Osteoarthritis, Knee; Oxycodone; Phenols; Tapentadol; Vomiting | 2017 |
Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone.
Topics: Analgesics, Opioid; Constipation; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Naloxone; Orthopedic Procedures; Oxycodone; Pain Measurement; Pain, Postoperative; Phenols; Postoperative Nausea and Vomiting; Prospective Studies; Single-Blind Method; Tapentadol | 2017 |
An experimental study comparing the respiratory effects of tapentadol and oxycodone in healthy volunteers.
Topics: Adolescent; Adult; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxycodone; Reference Values; Respiration; Tapentadol; Young Adult | 2017 |
A randomized controlled trial comparing tapentadol with oxycodone in non-breastfeeding women post elective cesarean section.
Topics: Acute Pain; Adult; Analgesics, Opioid; Cesarean Section; Double-Blind Method; Female; Humans; Oxycodone; Pain Management; Pregnancy; Single-Blind Method; Tapentadol | 2019 |
Tapentadol vs oxycodone for postoperative pain treatment the first 7 days after total knee arthroplasty: a randomized clinical trial.
Topics: Analgesics, Opioid; Arthroplasty, Replacement, Knee; Delayed-Action Preparations; Double-Blind Method; Humans; Osteoarthritis, Knee; Oxycodone; Pain, Postoperative; Phenols; Tapentadol | 2021 |
Tapentadol versus oxycodone analgesia and side effects after laparoscopic hysterectomy: A randomised controlled trial.
Topics: Analgesia; Analgesics, Opioid; Chronic Pain; Double-Blind Method; Female; Humans; Hysterectomy; Laparoscopy; Oxycodone; Pain, Postoperative; Phenols; Tapentadol | 2021 |
Although tapentadol and oxycodone both increase colonic volume, tapentadol treatment resulted in softer stools and less constipation: a mechanistic study in healthy volunteers.
Topics: Colon; Constipation; Cross-Over Studies; Healthy Volunteers; Humans; Male; Oxycodone; Tapentadol | 2021 |
Tapentadol results in less deterioration of gastrointestinal function and symptoms than standard opioid therapy in healthy male volunteers.
Topics: Adrenergic Uptake Inhibitors; Adult; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Gastrointestinal Motility; Humans; Male; Oxycodone; Tapentadol; Young Adult | 2021 |
Tapentadol and oxycodone affect resting-state functional brain connectivity: A randomized, placebo-controlled trial.
Topics: Analgesics, Opioid; Brain; Cross-Over Studies; Double-Blind Method; Humans; Male; Oxycodone; Phenols; Tapentadol | 2021 |
Tapentadol and oxycodone reduce cingulate glutamate in healthy volunteers.
Topics: Analgesics; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Glutamic Acid; Healthy Volunteers; Humans; Oxycodone; Phenols; Tapentadol | 2022 |
The effects of tapentadol and oxycodone on central processing of tonic pain.
Topics: Adult; Analgesics, Opioid; Cold Temperature; Cross-Over Studies; Double-Blind Method; Electroencephalography; Humans; Male; Oxycodone; Pain Measurement; Pain Perception; Tapentadol; Young Adult | 2021 |
Influence of tapentadol and oxycodone on the spinal cord and brain using electrophysiology: a randomized, placebo-controlled trial.
Topics: Analgesics, Opioid; Brain; Double-Blind Method; Electrophysiology; Humans; Oxycodone; Phenols; Spinal Cord; Tapentadol | 2022 |
Physical activity in the first postoperative week in 132 knee arthroplasty patients randomized to 3 different analgesic regimens.
Topics: Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Arthroplasty, Replacement, Knee; Delayed-Action Preparations; Double-Blind Method; Exercise; Humans; Oxycodone; Phenols; Tapentadol | 2023 |
40 other study(ies) available for oxycodone and tapentadol
| Article | Year |
|---|---|
Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1.
Topics: Analgesics, Opioid; HEK293 Cells; Humans; Inhibitory Concentration 50; Models, Molecular; Organic Cation Transporter 1; Permeability; Protein Conformation | 2019 |
Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain.
Topics: Acute Disease; Analgesics, Opioid; Computer Simulation; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Humans; Markov Chains; Models, Econometric; Oxycodone; Pain; Pain Measurement; Pain, Postoperative; Phenols; Quality-Adjusted Life Years; Solubility; Tablets; Tapentadol | 2010 |
Synergistic antihypersensitive effects of pregabalin and tapentadol in a rat model of neuropathic pain.
Topics: Animals; Antihypertensive Agents; Behavior, Animal; Disease Models, Animal; Drug Synergism; gamma-Aminobutyric Acid; Ligation; Locomotion; Male; Morphine; Neuralgia; Oxycodone; Pain Threshold; Phenols; Pregabalin; Rats; Rats, Sprague-Dawley; Spinal Nerves; Tapentadol | 2011 |
Effect of tapentadol extended release on productivity: results from an analysis combining evidence from multiple sources.
Topics: Adult; Aged; Chronic Pain; Cohort Studies; Constipation; Cross-Sectional Studies; Delayed-Action Preparations; Double-Blind Method; Efficiency; Female; Humans; Male; Markov Chains; Middle Aged; Narcotics; Oxycodone; Phenols; Randomized Controlled Trials as Topic; Retrospective Studies; Surveys and Questionnaires; Tapentadol | 2012 |
Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine.
Topics: Analgesics, Opioid; Chronic Pain; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Markov Chains; Morphine; Oxycodone; Phenols; Quality-Adjusted Life Years; Retrospective Studies; Severity of Illness Index; State Medicine; Surveys and Questionnaires; Tapentadol; United Kingdom | 2012 |
Pharmacokinetic and pharmacodynamic modeling of opioid-induced gastrointestinal side effects in patients receiving tapentadol IR and oxycodone IR.
Topics: Female; Gastrointestinal Tract; Humans; Male; Middle Aged; Oxycodone; Phenols; Proportional Hazards Models; Receptors, Opioid, mu; Tapentadol | 2012 |
Letter: effects of oxycodone and tapentadol dosage on gastrointestinal function.
Topics: Analgesics, Opioid; Dose-Response Relationship, Drug; Gastric Emptying; Humans; Oxycodone; Phenols; Randomized Controlled Trials as Topic; Tapentadol | 2012 |
Clinical simulation model of long-acting opioids for treatment of chronic non-cancer pain in the United States.
Topics: Analgesics, Opioid; Chronic Pain; Computer Simulation; Costs and Cost Analysis; Delayed-Action Preparations; Dose-Response Relationship, Drug; Health Expenditures; Humans; Monte Carlo Method; Outcome Assessment, Health Care; Oxycodone; Phenols; Tapentadol; United States | 2013 |
Comparison of opioid doctor shopping for tapentadol and oxycodone: a cohort study.
Topics: Analgesics, Opioid; Cohort Studies; Databases, Factual; Drug Prescriptions; Female; Humans; Longitudinal Studies; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Phenols; Physicians; Retrospective Studies; Risk Assessment; Tapentadol; Treatment Outcome | 2013 |
Real-world treatment pattern and outcomes among patients who took tapentadol IR or oxycodone IR.
Topics: Adult; Aged; Analgesics, Opioid; Female; Health Expenditures; Health Services; Humans; Length of Stay; Male; Middle Aged; Oxycodone; Pain; Phenols; Retrospective Studies; Tapentadol | 2013 |
Budget impact analysis of tapentadol extended release for the treatment of moderate to severe chronic noncancer pain.
Topics: Analgesics, Opioid; Budgets; Chronic Pain; Cost Savings; Costs and Cost Analysis; Delayed-Action Preparations; Formularies as Topic; Health Care Costs; Humans; Models, Economic; Oxycodone; Phenols; Severity of Illness Index; Tapentadol; United States | 2013 |
Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study.
Topics: Adult; Aged; Analgesics, Opioid; Cohort Studies; Databases, Factual; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; International Classification of Diseases; Male; Middle Aged; Odds Ratio; Opioid-Related Disorders; Oxycodone; Pain; Phenols; Propensity Score; Retrospective Studies; Risk; Sample Size; Tapentadol | 2013 |
Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse.
Topics: Adult; Aged; Analgesics, Opioid; Cohort Studies; Databases, Factual; Drug Prescriptions; Drug-Seeking Behavior; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Phenols; Sex Factors; Tapentadol; United States | 2014 |
Opioids in the treatment of postoperative pain: old drugs with new options?
Topics: Acetaminophen; Analgesics, Opioid; Drug Combinations; Drug Therapy, Combination; Fentanyl; Humans; Morphine; Oxycodone; Pain, Postoperative; Phenols; Sufentanil; Tapentadol | 2014 |
Effect of the norepinephrine transporter (NET) inhibition on μ-opioid receptor (MOR)-induced anti-nociception in a bone cancer pain model.
Topics: Analgesics, Opioid; Animals; Bone Neoplasms; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice, Inbred C3H; Morphine; Neoplasm Transplantation; Norepinephrine Plasma Membrane Transport Proteins; Oxycodone; Pain; Phenols; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Opioid, mu; Tapentadol; Tramadol; Tumor Cells, Cultured | 2014 |
Effectiveness of opioid analgesics in chronic noncancer pain.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Female; Fentanyl; Humans; Hydromorphone; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Opioid-Related Disorders; Oxycodone; Pain Clinics; Pain Measurement; Personality; Phenols; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tapentadol; Treatment Outcome | 2015 |
Does therapeutic use of tapentadol cause false-positive urine screens for methadone or opiates?
Topics: Adult; Aged, 80 and over; Analgesics, Opioid; Chromatography, Gas; Chromatography, Liquid; False Positive Reactions; Female; Humans; Hydrocodone; Immunoenzyme Techniques; Male; Methadone; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Phenols; Predictive Value of Tests; Reproducibility of Results; Substance Abuse Detection; Tandem Mass Spectrometry; Tapentadol; Urinalysis | 2015 |
[Sustained-release Opioids: Morphine, Oxycodone and Tapentadol].
Topics: Analgesics, Opioid; Delayed-Action Preparations; Drug Delivery Systems; Humans; Japan; Morphine; Oxycodone; Pain; Phenols; Tapentadol | 2015 |
[Dual effect prevents chronic course].
Topics: Chronic Pain; Delayed-Action Preparations; Drug Combinations; Humans; Naloxone; Oxycodone; Phenols; Tapentadol | 2015 |
A tapentadol related fatality: Case report with postmortem concentrations.
Topics: Adult; Analgesics, Opioid; Female; Gastrointestinal Contents; Humans; Liver; Oxycodone; Phenols; Suicide; Tapentadol; Vitreous Body | 2016 |
Assessment of Tapentadol API Abuse Liability With the Researched Abuse, Diversion and Addiction-Related Surveillance System.
Topics: Analgesics, Opioid; Chronic Pain; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Retrospective Studies; Substance-Related Disorders; Tapentadol | 2018 |
[Combination Therapy of Oxycodone and Tapentadol Was Effective for Intractable Pain Caused by Breast Cancer Bone Metastasis - A Case Report].
Topics: Analgesics, Opioid; Bone Neoplasms; Breast Neoplasms; Female; Humans; Middle Aged; Oxycodone; Pain, Intractable; Phenols; Tapentadol | 2018 |
Pharmaceutical payments to physicians may increase prescribing for opioids.
Topics: Analgesics, Opioid; Disclosure; Drug Industry; Fentanyl; Humans; Hydrocodone; Marketing; Medicare Part D; Morphine; Multivariate Analysis; Oxycodone; Physicians; Practice Patterns, Physicians'; Tapentadol; United States | 2019 |
Outcomes Associated with Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK Primary Care Observational Study.
Topics: Adult; Aged; Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Morphine; Oxycodone; Pain Management; Tapentadol; United Kingdom | 2019 |
Current Status of Adverse Events Related with Opioid Analgesics in Japan: Assessment Based on Japanese Adverse Drug Event Report Database.
Topics: Adverse Drug Reaction Reporting Systems; Analgesics, Opioid; Databases, Factual; Fentanyl; Humans; Japan; Methadone; Morphine; Oxycodone; Tapentadol | 2019 |
'Extreme personal stress' and 'a lot of pain': Exploring the physical, mental and social contexts of extramedical pharmaceutical opioid use in Australian paramedic case descriptions.
Topics: Adult; Allied Health Personnel; Analgesics, Opioid; Australia; Female; Humans; Male; Middle Aged; Oxycodone; Pain; Prescription Drug Misuse; Social Environment; Stress, Psychological; Tapentadol | 2020 |
Bone fractures in patients using tapentadol or oxycodone: an exploratory US claims database study.
Topics: Administrative Claims, Healthcare; Adult; Aged; Analgesics, Opioid; Back Pain; Databases, Factual; Female; Fractures, Bone; Humans; Male; Medicare; Middle Aged; Osteoarthritis; Oxycodone; Pain, Postoperative; Pilot Projects; Retrospective Studies; Tapentadol; United States | 2021 |
Gastrointestinal Adverse Events in Hospitalized Patients Following Orthopedic Surgery: Tapentadol Immediate Release Versus Oxycodone Immediate Release.
Topics: Adult; Aged; Double-Blind Method; Female; Humans; Middle Aged; Orthopedic Procedures; Oxycodone; Phenols; Retrospective Studies; Tapentadol | 2021 |
Comparison of opioid prescribing upon hospital discharge in patients receiving tapentadol versus oxycodone following orthopaedic surgery.
Topics: Adult; Aged; Analgesics, Opioid; Female; Hospital to Home Transition; Hospitals; Humans; Orthopedic Procedures; Oxycodone; Patient Discharge; Phenols; Practice Patterns, Physicians'; Retrospective Studies; Tapentadol | 2021 |
Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Hydromorphone; Japan; Male; Methadone; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Pain Measurement; Retrospective Studies; Tapentadol | 2021 |
Cost-Effectiveness Analysis of Tapentadol Versus Oxycodone/Naloxone in both Branded and Generic Formulations in Patients with Musculoskeletal Pain.
Topics: Analgesics, Opioid; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Musculoskeletal Pain; Naloxone; Oxycodone; Phenols; State Medicine; Tapentadol | 2021 |
Cost-effectiveness of tapentadol immediate release versus oxycodone immediate release for acute post-operative pain after major hip surgeries.
Topics: Adult; Analgesics, Opioid; Australia; Cost-Benefit Analysis; Humans; Oxycodone; Pain, Postoperative; Phenols; Tapentadol | 2022 |
Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study.
Topics: Analgesics, Opioid; Australia; Humans; Internet; Oxycodone; Tapentadol | 2021 |
Incidence of Delirium With Different Oral Opioids in Previously Opioid-Naive Patients.
Topics: Analgesics, Opioid; Delirium; Humans; Incidence; Morphine; Oxycodone; Tapentadol | 2022 |
Tapentadol shows lower intrinsic efficacy at µ receptor than morphine and oxycodone.
Topics: Analgesics, Opioid; Animals; Cell Line, Tumor; Humans; Mice; Morphine; Oxycodone; Receptors, Opioid, mu; Tapentadol | 2022 |
Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing tapentadol and oxycodone in Australia.
Topics: Aftercare; Analgesics, Opioid; Australia; Humans; Observational Studies as Topic; Opioid-Related Disorders; Oxycodone; Patient Discharge; Retrospective Studies; Tapentadol | 2022 |
A Comparison of Institutional Opioid Equianalgesia Tools: A National Study.
Topics: Administration, Oral; Analgesics, Opioid; Fentanyl; Humans; Hydrocodone; Hydromorphone; Levorphanol; Morphine; Oxycodone; Tapentadol; Tramadol | 2022 |
Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study.
Topics: Analgesics, Opioid; Cancer Pain; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Female; Humans; Morphine; Naloxone; Oxycodone; Pharmacogenomic Testing; Quality of Life; Tapentadol | 2022 |
Prescribing trend of tapentadol in a Sydney local health district.
Topics: Analgesics, Opioid; Australia; Delayed-Action Preparations; Humans; Morphine; Oxycodone; Pain, Postoperative; Phenols; Tapentadol; Tramadol | 2022 |
Effect of discharge opioid on persistent postoperative opioid use: a retrospective cohort study comparing tapentadol with oxycodone.
Topics: Analgesics, Opioid; Humans; Opioid-Related Disorders; Oxycodone; Patient Discharge; Phenols; Retrospective Studies; Tapentadol | 2023 |